glp-1 obesity drug study august 2025 Market GLP-1 agonists and changes in
Description
The endocrinology market is witnessing impressive growth it is growing at a compound annual growth rate (CAGR) of 7.82 percent
The difference is in the branding and dosing, otherwise, it is the same medication
The condition occurs when digestive enzymes activate and attack the pancreas, and can lead to organ damage if untreated
doi: 10.3760/cma.j.issn.0366-6999.2012.08.018 99 ZhuTWuXLZhangWXiaoM
